Chromatin Proteins and Transcription Factors as Therapeutic Targets /

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Donev, Rossen (Επιμελητής έκδοσης)
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cambridge, MA : Academic Press is an imprint of Elsevier, 2017.
Σειρά:Advances in protein chemistry and structural biology ; v. 107.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03342nam a2200529 4500
001 ocn973396828
003 OCoLC
005 20180501122035.0
006 m o d
007 cr cnu|||unuuu
008 170222s2017 maua o 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d OPELS  |d IDEBK  |d EBLCP  |d N$T  |d YDX  |d OCLCF  |d OCLCQ  |d MEU  |d GrThAP 
066 |c (S 
019 |a 973506691  |a 973755068  |a 973798715  |a 973907039  |a 974033102  |a 1028922417  |a 1030785129 
020 |a 9780128123911  |q (electronic bk.) 
020 |a 0128123915  |q (electronic bk.) 
020 |a 9780128123904  |q (print) 
020 |a 0128123907 
035 |a (OCoLC)973396828  |z (OCoLC)973506691  |z (OCoLC)973755068  |z (OCoLC)973798715  |z (OCoLC)973907039  |z (OCoLC)974033102  |z (OCoLC)1028922417  |z (OCoLC)1030785129 
050 4 |a QH599  |b .C47 2017eb 
072 7 |a SCI  |x 007000  |2 bisacsh 
072 7 |a SCI  |2 ukslc 
082 0 4 |a 572.8/7  |2 23 
049 |a TEFA 
245 0 0 |a Chromatin Proteins and Transcription Factors as Therapeutic Targets /  |c edited by Rossen Donev. 
264 1 |a Cambridge, MA :  |b Academic Press is an imprint of Elsevier,  |c 2017. 
300 |a 1 online resource (xvi, 369 pages :  |b color illustrations). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in protein chemistry and structural biology ;  |v volume 107 
546 |a Text in English. 
500 |a Includes indexes. 
588 0 |a Online resource; title from PDF title page (ScienceDirect, viewed February 24, 2017). 
505 8 |a 2.2.1. Posttranslational Acetylation2.2.2. Oxidation; 2.3. HMGB1-Receptor Families; 2.3.1. Receptor for Advanced Glycation End Products; 2.3.2. Toll-Like Receptors; 2.3.3. Recently Discovered HMGB1 Receptors; 3. HMGB1 in the Nucleus-An Architectural Factor; 3.1. Nucleolar Functions; 3.1.1. DNA Replication, Repair, and V(D)J Recombination; 3.1.2. Gene Transcription Transfer and Delivery; 3.1.3. Nucleosome Structure and Dynamics; 3.1.4. Telomere Homeostasis; 3.2. HMGB1 as a Damage Recognition Protein Mediating the Antitumor Effect of the Chemotherapeutic Drug cis-Platin 
505 8 |a 3.3. HMGB1 Protein-An Important Player in cis-platin-Based Therapy3.3.1. HMGB1 Affects the Repair of DNA Damaged by the Antitumor Drug cis-Platin In Vitro; 3.3.2. The Impact of HMGB1 Protein for the Repair Potential of Human Cancer Cell Lines: A Significant Issue for Therapeut ...; 4. HMGB1 Outside the Cell; 4.1. HMGB1 as a Signaling Molecule; 4.2. HMGB1 and Diseases; 5. HMGB1 as a Therapeutic Target; 5.1. Antibody-Based Targeting; 5.2. Peptides and Protein Inhibitors of HMGB1; 5.3. Blockage of HMGB1-Receptor Signaling; 5.4. Small Molecules Inhibiting HMGB1 
504 |a Includes bibliographical references and indexes. 
650 0 |a Chromatin. 
650 0 |a Transcription factors. 
650 7 |a SCIENCE / Life Sciences / Biochemistry  |2 bisacsh 
650 7 |a Chromatin.  |2 fast  |0 (OCoLC)fst00859922 
650 7 |a Transcription factors.  |2 fast  |0 (OCoLC)fst01154564 
655 4 |a Electronic books. 
700 1 |a Donev, Rossen,  |e editor. 
776 0 8 |c Original  |z 0128123907  |z 9780128123904  |w (OCoLC)959869209 
830 0 |a Advances in protein chemistry and structural biology ;  |v v. 107. 
856 4 0 |u https://www.sciencedirect.com/science/bookseries/18761623/107  |z Full Text via HEAL-Link